Patents Assigned to Innovation Pharmaceuticals Inc.
  • HOST DEFENSE PROTEIN (HDP) MIMETICS FOR PROPHYLAXIS AND/OR TREATMENT OF INFLAMMATORY DISEASES OF THE GASTROINTESTINAL TRACT
    Publication number: 20230310435
    Abstract: The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.
    Type: Application
    Filed: May 8, 2023
    Publication date: October 5, 2023
    Applicant: INNOVATION PHARMACEUTICALS INC.
    Inventor: Krishna MENON
  • Arylamide compounds for treatment and prevention of viral infections
    Patent number: 11771694
    Abstract: The present disclosure provides methods for treating or preventing a viral infection with one or more arylamide compounds, or pharmaceutically acceptable salts thereof, or compositions comprising the same, and pharmaceutical compositions comprising one or more arylamide compounds and at least one antiviral agent.
    Type: Grant
    Filed: June 4, 2021
    Date of Patent: October 3, 2023
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Jane A. Harness, Leo Ehrlich, Warren Kyle Weston
  • Host defense protein (HDP) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract
    Patent number: 11666571
    Abstract: The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.
    Type: Grant
    Filed: August 12, 2020
    Date of Patent: June 6, 2023
    Assignee: INNOVATION PHARMACEUTICALS INC.
    Inventor: Krishna Menon
  • Host Defense Protein (HDP) Mimetics For Prophylaxis And/Or Treatment Of Inflammatory Diseases Of The Gastrointestinal Tract
    Publication number: 20200368232
    Abstract: The present invention provides methods for treating and/or preventing inflammatory diseases of the gastrointestinal tract with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, and the use of compositions comprising the same.
    Type: Application
    Filed: August 12, 2020
    Publication date: November 26, 2020
    Applicant: INNOVATION PHARMACEUTICALS INC.
    Inventor: Krishna MENON
  • Compounds for use in treatment of mucositis
    Patent number: 10603294
    Abstract: The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: March 31, 2020
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak
  • Compounds for use in treatment of mucositis
    Patent number: 10206894
    Abstract: The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: September 12, 2017
    Date of Patent: February 19, 2019
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak
  • Arylamide compounds and compositions and uses thereof
    Patent number: 10166232
    Abstract: The present invention discloses ophthalmic and otic compositions of facially amphiphilic antimicrobial polymers and oligomers and their uses, including their use in methods for treating and preventing ophthalmic infections and otic infections in humans and animals.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: January 1, 2019
    Assignee: Innovation Pharmaceuticals Inc.
    Inventor: Richard W. Scott
  • Compounds for use in treatment of mucositis
    Patent number: 9795575
    Abstract: The present invention provides methods for treating and/or preventing mucositis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
    Type: Grant
    Filed: August 17, 2016
    Date of Patent: October 24, 2017
    Assignee: Innovation Pharmaceuticals Inc.
    Inventors: Richard W. Scott, Bozena Korczak